Muhammad Ibrahim on Efficacy and Safety of Extended DOACs Use in VTE
Muhammad Ibrahim, Medical Researcher at Research Council of Pakistan, shared on LinkedIn:
”Excited to co-author this amazing systematic review and meta-analysis entitled: Efficacy and Safety of Direct Oral Anticoagulants for Extended Treatment of Venous Thromboembolism.
Clinical question: Should we continue DOACs long-term after initial VTE treatment?
Analysis of 5,600+ patients from RCTs showed:
83% reduction in VTE recurrence
62% reduction in all-cause mortality
No significant increase in major bleeding
Higher clinically relevant non-major bleeding
Bottom line: In properly selected, low-bleeding-risk patients, extended DOAC therapy provides a clear net clinical benefit for secondary prevention of VTE.
Special thanks to Saad Ahmed Waqas for giving me the opportunity to work on and help lead this project.
Read here.
Congratulations to the co-authors: Muhammad Waqas, Muhammad Ahmed, Maimoona Nasir, Muhammad Khalid Afridi, Gregg C. Fonarow.”
Article: Efficacy and Safety of Direct Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors: Waqas Muhammad, Muhammad Ahmed, Muhammad Ibrahim, Maimoona Nasir, Muhammad Khalid Afridi, Gregg C. Fonarow, Saad Ahmed Waqas
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?